Does it make a difference where you inject semaglutide?

Semaglutide is licensed for subcutaneous injection into three sites: abdomen, outer thigh, and upper arm — all are clinically acceptable and produce reliable absorption when used correctly.
Rotating sites week by week prevents lipohypertrophy (lumpy, hardened tissue from repeated injections into the same spot), which can reduce absorption unpredictably.
The abdomen is most commonly chosen because it is easy to reach and pinch; the thigh is a practical alternative; the upper arm generally requires a second person or injection aid.
Small practical details (needle length, skin-pinch technique, and avoiding bruised or irritated skin) affect comfort and consistency more than which of the three sites you choose.

Yes, injection site does matter for semaglutide — though perhaps not in the way most people expect. The medicine absorbs reliably from three licensed areas (abdomen, thigh, upper arm), but rotating between those sites each week is what keeps absorption consistent and your skin healthy over the long term. These are prescription-only medicines; a prescriber and the Patient Information Leaflet guide the specifics of your own routine. The full Wegovy overview on our site sets out what treatment involves from week one. What follows is a practical, step-by-step look at how site choice actually affects the medicine and what good rotation looks like in practice.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

A step-by-step guide to semaglutide injection sites and why each choice matters

Step 1: understand which three areas are licensed and why they work

Semaglutide (Wegovy) is injected subcutaneously, into the fat layer just beneath the skin, not into muscle. The three approved injection areas are the abdomen (at least 5 cm away from the navel), the front or outer thigh, and the back of the upper arm. Each site has a sufficient layer of subcutaneous tissue in most adults, which is what allows the medicine to be absorbed steadily into the bloodstream rather than spiking or pooling. The NHS semaglutide medicines page confirms all three as suitable.

A common assumption is that one site produces faster or stronger effects than the others. The evidence does not support that idea in any clinically meaningful way for standard semaglutide use. What matters far more is consistency: injecting into healthy, unaffected tissue every time. If you have been using the same spot for weeks, you may already have small areas of thickened tissue that absorb the medicine less predictably, which is exactly why site rotation exists as a rule, not a suggestion.

The upper arm deserves a practical note. It is perfectly valid, but reaching it solo with a pre-filled pen is awkward; many people reserve it for weeks when a partner or carer can assist, and if you are curious about how the device itself affects your technique, our page covering the different Wegovy pens available explains the design differences that can make certain sites easier to reach. The abdomen and thigh are usually easier to manage independently. Our guide on exactly where to inject semaglutide maps each area in more detail.

Step 2: build a rotation plan before your second injection

Rotation is easier to maintain when it is planned rather than improvised. A simple approach: divide each site into quadrants and move clockwise through them before returning to the start. So if week one uses the lower-right abdomen, week two might use the upper-right, then upper-left, then lower-left, before beginning again. The same logic applies to the thigh and upper arm.

Staying at least 2–3 cm from any previous injection mark is a reasonable target. Skin that still has a small bruise, looks red, or feels tender from last week's injection is best avoided, not because it is dangerous to inject nearby, but because it is more likely to sting and may absorb the medicine differently while the tissue is recovering. Practical injection technique for semaglutide covers the pinch-and-hold steps in full.

One detail worth knowing: avoid injecting through clothing or into skin that has just been exercised vigorously. Increased local blood flow in worked muscle does not directly affect subcutaneous absorption, but the guidance is to avoid the site for at least an hour after vigorous activity, principally for comfort. Your Patient Information Leaflet gives the complete list of things to check before each injection.

Step 3: what to do if a site becomes uncomfortable over time

Lipohypertrophy (the small, rubbery lumps that develop from repeated injections in the same spot) is the most practical reason site rotation matters. It is not painful in itself, but injecting into affected tissue can mean the medicine sits in a less vascular environment and absorbs inconsistently. Some people notice their appetite suppression feels less reliable in the weeks after they have inadvertently camped on one area of the abdomen; once they rotate properly, things settle. That is not a guaranteed pattern, but it is why the guidance exists.

If you notice persistent lumps, firmness, or discolouration at your injection sites, flag it at your next review. Avoiding the area for several weeks usually allows the tissue to recover. The dedicated page on whether Wegovy injection site makes a difference goes deeper on this topic, including what the tissue changes actually look like.

Alcohol swabs before injection are standard practice for many patients; medical-grade alcohol swabs are one way to keep a supply at home without over-ordering. After swabbing, let the skin dry fully before injecting, a wet surface can sting more. It is a small detail, but the kind of thing our prescribers find themselves mentioning fairly often because it genuinely helps.

Step 4: storage, travel, and keeping the pen ready for the right site

Injection site choices are also shaped by practical storage and pen readiness. Semaglutide must be kept refrigerated at 2–8°C; a pen taken straight from the fridge can cause more discomfort at the injection site because of the cold. Allowing it to sit at room temperature for around 30 minutes before injecting (as noted in the leaflet) makes the injection noticeably more comfortable regardless of which site you choose. Semaglutide storage guidance covers the refrigeration rules and the limited room-temperature window in full, which matters if you are travelling.

If you are considering Wegovy or already partway through treatment and would like your current injection routine reviewed, our prescribers can look at that as part of an ongoing clinical assessment. Check your eligibility and start a free consultation, a real clinician reads every submission the same day.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions